Bionano Genomics Inc
BNGO
Market Cap$108.87M
Close$
$1.11
0.1% downside
Current Fair Value
0.1% downsideOvervalued by 0.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $108.87 Million |
|---|---|
| Enterprise Value | $121.29 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-6.81 |
| Beta | 2.65 |
| Outstanding Shares | 66,856,804 |
| Avg 30 Day Volume | 1,179,795 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.28 |
|---|---|
| PEG | 1.84 |
| Price to Sales | - |
| Price to Book Ratio | 1.11 |
| Enterprise Value to Revenue | 3.24 |
| Enterprise Value to EBIT | -0.96 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.34 |
| Debt to Equity | 0.49 |
Revenue Sources
No data
ESG Score
No data
About Bionano Genomics Inc
147 employees
CEO: R. Erik Holmlin